Workflow
Quarterly Earnings
icon
Search documents
Otis Worldwide Q2 Preview: Anticipating Weak Equipment Sales
Seeking Alpha· 2025-07-10 19:47
Core Insights - The article does not provide specific company or industry insights, focusing instead on disclosures and disclaimers related to investment positions and advice [1][2] Group 1 - There are no stock, option, or similar derivative positions held by the analyst in any mentioned companies [1] - The article expresses personal opinions and is not compensated beyond Seeking Alpha [1] - The views may not reflect those of Seeking Alpha as a whole, and the analysts may not be licensed or certified [2]
Top Wall Street Forecasters Revamp Franklin Covey Expectations Ahead Of Q3 Earnings
Benzinga· 2025-06-30 14:04
Franklin Covey Co. FC will release earnings results for the third quarter, before the opening bell on Wednesday, July 2. Read This Next: Photo via Shuttestock Loading... Loading... On June 10, FranklinCovey named Dariusz Paczuski as Chief Marketing Officer. Franklin Covey shares gained 0.3% to close at $23.38 on Friday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables. Let' ...
Micron reports quarterly earnings beat driven by record DRAM revenue
Proactiveinvestors NA· 2025-06-25 20:27
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Why Uxin Stock Was Crushing It This Week
The Motley Fool· 2025-06-13 11:45
Over the past few days, investors have clearly liked what they see on Uxin's (UXIN -8.26%) lot. The Chinese operator of used-car dealerships saw its share price accelerate 7% higher week to date as of early Friday morning, according to data compiled by S&P Global Market Intelligence, thanks mainly to an inspiring quarterly earnings report.Notable improvements in first-quarter fundamentalsThe market was cheered by Uxin's first-quarter performance, not least because the auto retailer posted some impressive ye ...
Markets Mostly Flat; Big Afternoon for Earnings: WDAY, DECK, INTU & More
ZACKS· 2025-05-22 23:00
Market Overview - Market indexes showed resilience against high bond yields, with the 30-year bond yield at +5.05%, the highest in 18 years, but moderated from previous spikes [1] - Major indexes finished flat, with the Dow, S&P 500, and Russell 2000 remaining unchanged, while the Nasdaq closed up +53 points (+0.28%) [2] - Despite being in the red over the past five trading days, the indexes have seen double-digit gains over the past month [2] Quarterly Earnings Summary - **Workday (WDAY)**: Reported Q1 earnings of $2.23 per share on $2.4 billion in sales, beating previous figures of $1.99 per share and $2.22 billion. However, shares fell -5% due to steady guidance and reduced capex spending [3] - **Deckers Outdoor (DECK)**: Earnings of $1.00 per share exceeded the Zacks consensus of 57 cents, with revenues of $1.02 billion surpassing expectations of $988.6 million. Shares dropped -11% due to lower-than-expected guidance for the current quarter and full-year guidance held back due to tariff issues [3] - **Intuit (INTU)**: Surpassed earnings expectations with $11.65 per share against a consensus of $10.89, and revenues of $7.75 billion exceeding the $7.54 billion forecast. Shares rose +5% following a significant increase in next-quarter guidance driven by Credit Karma growth [4] - **Ross Stores (ROST)**: Beat earnings estimates by 4 cents with $1.47 per share on $4.98 billion in revenues, slightly above consensus. Same-store sales were flat but improved from a projected decline. Shares fell -9% due to lower next-quarter earnings guidance attributed to tariff pressures [5] - **AutoDesk (ADSK)**: Reported Q1 earnings of $2.29 per share, beating the anticipated $2.14, with revenues of $1.63 billion slightly above the forecast of $1.61 billion. Shares gained +5% due to positive next-quarter guidance [6]
Planet Fitness Misses Q1 Earnings & Revenue Mark, Retains '25 View
ZACKS· 2025-05-09 15:15
Core Insights - Planet Fitness, Inc. (PLNT) reported lower-than-expected first-quarter 2025 results, with adjusted earnings and revenues missing the Zacks Consensus Estimate, although both metrics increased year-over-year [1][4] - The company is facing macroeconomic volatility, increased costs, and expenses, particularly in SG&A and club operations [1][2] Financial Performance - Adjusted earnings per share (EPS) for Q1 2025 were 59 cents, missing the consensus estimate of 62 cents by 4.8%, while the prior-year quarter reported adjusted EPS of 53 cents [4] - Quarterly revenues were $276.7 million, lagging the consensus mark of $282 million by 1.7%, but rose 11.5% year-over-year due to new club openings and membership growth [4] - Adjusted EBITDA was $117 million, up 10% from $106.3 million reported in the year-ago quarter [5] Segment Performance - Franchise segment revenues rose 10.7% year-over-year to $115.2 million, with adjusted EBITDA of $84.9 million, up from $76.1 million [6] - Corporate-owned clubs generated revenues of $133.7 million, up 9.2% year-over-year, with adjusted EBITDA totaling $45.8 million, an increase from $42.4 million [7] - Equipment segment revenues totaled $27.8 million, up 28.7% year-over-year, with adjusted EBITDA rising to $7.4 million from $4.8 million [8] Cash and Debt Position - As of March 31, 2025, Planet Fitness had cash and cash equivalents of $343.9 million, up from $293.2 million at the end of 2024, while long-term debt decreased slightly to $2.14 billion [9] 2025 Outlook - For 2025, the company expects approximately 130-140 new equipment placements and 160-170 new club openings, with same-club sales growth projected in the 5-6% range [10] - Revenues are anticipated to increase approximately 10% from 2024 levels, with adjusted EBITDA and net income expected to grow around 10% and 8-9%, respectively [11] - Capital expenditures are now projected to increase approximately 20%, a revision from the previously expected 25% increase [12]
Marathon Petroleum Q1 Loss Narrower Than Expected, Revenues Beat
ZACKS· 2025-05-09 11:30
Independent oil refiner and marketer Marathon Petroleum Corporation (MPC) reported a first-quarter 2025 adjusted loss per share of 24 cents, narrower than the Zacks Consensus Estimate of a loss of 63 cents. This primarily reflects the stronger-than-expected performance of its Refining & Marketing segment. The adjusted EBITDA of the segment totaled $489 million, surpassing the consensus mark of $286 million on the back of lower costs and higher throughput.However, the company’s bottom line fell sharply from ...
Crocs (CROX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-05-08 14:36
Crocs (CROX) reported $937.33 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.1%. EPS of $3.00 for the same period compares to $3.02 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $909.56 million, representing a surprise of +3.05%. The company delivered an EPS surprise of +19.52%, with the consensus EPS estimate being $2.51.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...
EyePoint Pharmaceuticals (EYPT) Reports Q1 Earnings: What Key Metrics Have to Say
ZACKS· 2025-05-07 14:36
Core Insights - EyePoint Pharmaceuticals reported a revenue of $24.45 million for the quarter ended March 2025, marking a significant increase of 109.4% year-over-year [1] - The company's earnings per share (EPS) was -$0.65, slightly worse than the -$0.55 EPS from the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate by 345.17%, which was set at $5.49 million [1] - The consensus EPS estimate was also -$0.65, indicating no EPS surprise [1] Revenue Breakdown - Royalty income reached $12.69 million, significantly surpassing the three-analyst average estimate of $0.33 million [4] - Product sales, net, amounted to $0.72 million, slightly below the two-analyst average estimate of $0.85 million [4] - Revenue from license and collaboration agreements was $11.05 million, exceeding the average estimate of $6.90 million based on two analysts [4] Stock Performance - EyePoint Pharmaceuticals' shares have returned +51.3% over the past month, outperforming the Zacks S&P 500 composite, which saw a +10.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]
Teva Pharmaceutical Industries (TEVA) Reports Q1 Earnings: What Key Metrics Have to Say
ZACKS· 2025-05-07 14:36
Teva Pharmaceutical Industries Ltd. (TEVA) reported $3.89 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.9%. EPS of $0.52 for the same period compares to $0.48 a year ago.The reported revenue represents a surprise of -1.92% over the Zacks Consensus Estimate of $3.97 billion. With the consensus EPS estimate being $0.47, the EPS surprise was +10.64%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street exp ...